APA-viite

Jansåker, F., Thønnings, S., Hertz, F. B., Kallemose, T., Værnet, J., Bjerrum, L., . . . Knudsen, J. D. (2019). Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial(). EClinicalMedicine.

Chicago-tyylinen lähdeviittaus

Jansåker, Filip, Sara Thønnings, Frederik Boëtius Hertz, Thomas Kallemose, Jan Værnet, Lars Bjerrum, Thomas Benfield, Niels Frimodt-Møller, ja Jenny Dahl Knudsen. "Three Versus Five Days of Pivmecillinam for Community-acquired Uncomplicated Lower Urinary Tract Infection: A Randomised, Double-blind, Placebo-controlled Superiority Trial()." EClinicalMedicine 2019.

MLA-viite

Jansåker, Filip, et al. "Three Versus Five Days of Pivmecillinam for Community-acquired Uncomplicated Lower Urinary Tract Infection: A Randomised, Double-blind, Placebo-controlled Superiority Trial()." EClinicalMedicine 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.